1. Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancer

   • Prasad Sanjay Dhiwar
   • Gurubasavaraja Swamy Purwarga Matada
   • Pujan Sasmal

   Review Paper 26 July 2022 Pages: 1401 - 1413

   

2. The SAR-based development of small molecular HBV capsid assembly modulators

   • Yunwen Wang
   • Shendan Wang
   • Rong Sheng

   Review Article 26 July 2022 Pages: 1414 - 1430

   

3. Design, synthesis, in vivo and in silico evaluation of novel benzothiazole-hydrazone derivatives as new antiepileptic agents

   • Himanshu Singh
   • Rajnish Kumar
   • Mohd. Mustaqeem Abdullah

   Original Research 01 July 2022 Pages: 1431 - 1447

   

4. Synthesis and evaluation of new 2-oxo-1,2-dihydroquinoline-3-carboxamides as potent inhibitors against acetylcholinesterase enzyme

   • Muhammed Alzweiri
   • Kamal Sweidan
   • Tamam Al-Helo

   Original Research 04 July 2022 Pages: 1448 - 1460

   

5. Synthesis, bacterial and fungal inhibition assay, molecular docking study of substituted isatin (N-substituted 1,2,3,4-tetra-O-acetyl-β-glucopyranosyl)thiosemicarbazones

   • Nguyen Thi Kim Giang
   • Nguyen Dinh Thanh
   • Hoang Thi Kim Van

   Original Research 06 July 2022 Pages: 1461 - 1475

   

6. 4,5-diazafenylfluorene-rhodanine conjugates promote anoikis in A375 cells via inhibiting PPAR-γ expression

   • Qiang Yin
   • Annoor Awadasseid
   • Wen Zhang

   Original Research 13 July 2022 Pages: 1476 - 1487

   

7. Antimicrobial activity of some celastroloids and their derivatives

   • Marielle Cascaes Inácio
   • Tiago Antunes Paz
   • A. A. Leslie Gunatilaka

   Original Research 13 July 2022 Pages: 1488 - 1499

   

8. Design, synthesis, biological evaluation and in silico studies of EGFR inhibitors based on 4-oxo-chromane scaffold targeting resistance in non-small cell lung cancer (NSCLC)

   • Kshipra S. Karnik
   • Aniket P. Sarkate
   • Pravin S. Wakte

   Original Research 14 July 2022 Pages: 1500 - 1516

   

9. Triphenylpyrazoline ketone chlorophenols as potential candidate compounds against Parkinson’s disease: design, synthesis, and biological evaluation

   • Ning Ning Cheng
   • Le Hua Zhang
   • Qing Shan Li

   Original Research 20 July 2022 Pages: 1517 - 1544

   

10. Identification of CNS compatible small molecules as glycogen synthase kinase-3β (GSK-3β) inhibitors through structure-based virtual screening

    • Sukanya Sukanya
    • Bhanwar Singh Choudhary
    • Ruchi Malik

    Original Research 27 July 2022 Pages: 1545 - 1557

    

11. Design, synthesis, and antimicrobial evaluation of novel 10-Undecenoic acid-based lipidic triazoles

    • B. Gandhi
    • K. Greeshma
    • Shiva Shanker Kaki

    Original Research 28 July 2022 Pages: 1558 - 1570

    

12. Design, synthesis, antiproliferative and antimicrobial evaluation of a new class of disulfides containing 1,3,4-thiadiazole units

    • Ruilian Zhang
    • Bo Li
    • Baoquan Chen

    Original Research 28 July 2022 Pages: 1571 - 1583

    

13. Tranilast-tyrosine hybrid molecule exhibits dual activity: suppression of epithelial-mesenchymal transition and induction of cytotoxicity in cancer cells

    • Tsugumasa Toma
    • Junpei Yamashita
    • Mikako Fujita

    Original Research 29 July 2022 Pages: 1584 - 1593

    

14. Synthesis, characterization, and biological evaluation of some novel ϒ-aminobutyric acid aminotransferase (GABA-AT) inhibitors

    • Sushant Kumar Shrivastava
    • Ojaswi Sinha
    • Poorvi Saraf

    Original Research 29 July 2022 Pages: 1594 - 1610

    

15. Synthesis, and docking studies of arylhydrazone compounds and evaluation of their platelet aggregation inhibitory effect and cytotoxicity

    • Maryam H. Klidsar
    • Marjan Esfahanizadeh
    • Farzad Kobarfard

    Original Research 29 July 2022 Pages: 1611 - 1620